| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 81 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 66 |
| 2 | TACROLIMUS OINTMENT 0.1% | 66 |
| 3 | CYCLOPHOSPHAMIDE | 41 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 41 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 41 |
| 6 | PREDNISONE | 41 |
| 7 | BLINATUMOMAB | 39 |
| 8 | MYCOPHENOLATE MOFETIL | 36 |
| 9 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 36 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NARSOPLIMAB | 1 | 0.0476 |
| 1 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 2 | BLINATUMOMAB | 39 | 0.0036 |
| 3 | ERAVACYCLINE | 1 | 0.0034 |
| 4 | QUIZARTINIB | 2 | 0.0028 |
| 5 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 1 | 0.0028 |
| 6 | INOTUZUMAB OZOGAMICIN | 8 | 0.0027 |
| 7 | PEGUNIGALSIDASE ALFA | 1 | 0.0027 |
| 8 | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 1 | 0.0025 |
| 9 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 6 | 0.0025 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 8 | 0.0027 |
| 1 | Anthracycline Topoisomerase Inhibitor [EPC] | 6 | 0.0025 |
| 2 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 5 | 0.0020 |
| 3 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 4 | 0.0012 |
| 4 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 20 | 0.0009 |
| 6 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 18 | 0.0008 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 9 | Sulfone [EPC] | 5 | 0.0005 |